Astrazeneca Pharma India Ltd
ASTRAZEN price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- ASTRAZEN
- MB Code
- MBEQU3575
- ISIN
- INE203A01020
- BSE code
- 506820
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 578.61 Cr
- Net profit
- 44.88 Cr
- EPS
- 17.95
- YoY revenue
- +20.42%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for ASTRAZEN
AstraZeneca Pharma India’s Q4FY26 net profit fell 23% to ₹44.8 crore despite 20.4% revenue growth to ₹578.6 crore; FY26 revenue reached ₹…
AstraZeneca Pharma India hit an all-time high after its Enhertu drug won FDA priority review, a regulatory step that can speed approval a…
Dividend of ₹32.00 per share
Ex-date corporate action
AstraZeneca India receives CDSCO approval for a new Imfinzi indication, allowing durvalumab with carboplatin and paclitaxel as a first-li…
AstraZeneca Pharma India Ltd., established in 1979, is a mid-cap company in the pharmaceuticals sector with a market cap of Rs 22,177.50 …
Price returns
Historical performance
Technicals
Indicator consensus